Service delivery interventions to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
29
06
2019
accepted:
27
12
2019
entrez:
14
1
2020
pubmed:
14
1
2020
medline:
16
4
2020
Statut:
epublish
Résumé
Voluntary medical male circumcision (VMMC) remains an essential component of combination HIV prevention services, particularly in priority countries in sub-Saharan Africa. As VMMC programs seek to maximize impact and efficiency, and to support World Health Organization guidance, specific uptake-enhancing strategies are critical to identify. We systematically reviewed the literature to evaluate the impact of service delivery interventions (e.g., facility layout, service co-location, mobile outreach) on VMMC uptake among adolescent and adult men. For the main effectiveness review, we searched for publications or conference abstracts that measured VMMC uptake or uptake of HIV testing or risk reduction counselling within VMMC services. We synthesized data by coding categories and outcomes. We also reviewed studies assessing acceptability, values/preferences, costs, and feasibility. Four randomized controlled trials and five observational studies were included in the effectiveness review. Studies took place in South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. They assessed a range of service delivery innovations, including community-, school-, and facility-based interventions. Overall, interventions increased VMMC uptake; some successfully improved uptake among age-specific subpopulations, but urban-rural stratification showed no clear trends. Interventions that increased adult men's uptake included mobile services (compared to static facilities), home-based testing with active referral follow-up, and facility-based HIV testing with enhanced comprehensive sexual education. Six acceptability studies suggested interventions were generally perceived to help men choose to get circumcised. Eleven cost studies suggested interventions create economies-of-scale and efficiencies. Three studies suggested such interventions were feasible, improving facility preparedness, service quality and quantity, and efficiencies. Innovative changes in male-centered VMMC services can improve adult men's and adolescent boys' VMMC uptake. Limited evidence on interventions that enhance access and acceptability show promising results, but evidence gaps persist due to inconsistent intervention definition and delivery, due in part to contextual relevance and limited age disaggregation.
Sections du résumé
BACKGROUND
Voluntary medical male circumcision (VMMC) remains an essential component of combination HIV prevention services, particularly in priority countries in sub-Saharan Africa. As VMMC programs seek to maximize impact and efficiency, and to support World Health Organization guidance, specific uptake-enhancing strategies are critical to identify.
METHODS
We systematically reviewed the literature to evaluate the impact of service delivery interventions (e.g., facility layout, service co-location, mobile outreach) on VMMC uptake among adolescent and adult men. For the main effectiveness review, we searched for publications or conference abstracts that measured VMMC uptake or uptake of HIV testing or risk reduction counselling within VMMC services. We synthesized data by coding categories and outcomes. We also reviewed studies assessing acceptability, values/preferences, costs, and feasibility.
RESULTS
Four randomized controlled trials and five observational studies were included in the effectiveness review. Studies took place in South Africa, Tanzania, Uganda, Zambia, and Zimbabwe. They assessed a range of service delivery innovations, including community-, school-, and facility-based interventions. Overall, interventions increased VMMC uptake; some successfully improved uptake among age-specific subpopulations, but urban-rural stratification showed no clear trends. Interventions that increased adult men's uptake included mobile services (compared to static facilities), home-based testing with active referral follow-up, and facility-based HIV testing with enhanced comprehensive sexual education. Six acceptability studies suggested interventions were generally perceived to help men choose to get circumcised. Eleven cost studies suggested interventions create economies-of-scale and efficiencies. Three studies suggested such interventions were feasible, improving facility preparedness, service quality and quantity, and efficiencies.
CONCLUSIONS
Innovative changes in male-centered VMMC services can improve adult men's and adolescent boys' VMMC uptake. Limited evidence on interventions that enhance access and acceptability show promising results, but evidence gaps persist due to inconsistent intervention definition and delivery, due in part to contextual relevance and limited age disaggregation.
Identifiants
pubmed: 31929587
doi: 10.1371/journal.pone.0227755
pii: PONE-D-19-17533
pmc: PMC6957297
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0227755Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIMH NIH HHS
ID : P30 MH062246
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH090173
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Glob Health Sci Pract. 2015 Sep 15;3(3):503-15
pubmed: 26374807
PLoS One. 2017 Jun 20;12(6):e0179854
pubmed: 28632768
PLoS Med. 2011 Nov;8(11):e1001129
pubmed: 22140364
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):e30-e37
pubmed: 27632232
BMC Health Serv Res. 2014 Jan 23;14:31
pubmed: 24450374
Lancet HIV. 2015 May;2(5):e181-9
pubmed: 26120594
Glob Public Health. 2015;10(5-6):739-56
pubmed: 25866013
Health Policy Plan. 2017 Dec 1;32(10):1407-1416
pubmed: 29029086
Lancet HIV. 2016 May;3(5):e212-20
pubmed: 27126488
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
AIDS Care. 2018 Sep;30(9):1071-1082
pubmed: 29566546
PLoS One. 2018 Apr 19;13(4):e0195691
pubmed: 29672578
PLoS Med. 2016 May 03;13(5):e1002012
pubmed: 27138961
AIDS. 2017 Apr 24;31(7):1025-1034
pubmed: 28350578
PLoS One. 2014 May 06;9(5):e85051
pubmed: 24802746
PLoS One. 2014 Nov 06;9(11):e111602
pubmed: 25375790
AIDS Behav. 2014 Sep;18(9):1764-75
pubmed: 25047688
J Clin Epidemiol. 2014 Jan;67(1):56-64
pubmed: 24189091
PLoS One. 2015 Dec 30;10(12):e0145729
pubmed: 26716442
Tanzan J Health Res. 2012 Jan;14(1):48-60
pubmed: 26591747
Int J Behav Med. 2018 Feb;25(1):123-130
pubmed: 28688094
J Acquir Immune Defic Syndr. 2016 Oct 1;72 Suppl 4:S304-S308
pubmed: 27749598
Glob Health Sci Pract. 2013 Mar 21;1(1):108-16
pubmed: 25276521
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
PLoS One. 2015 Nov 03;10(11):e0140818
pubmed: 26529596
PLoS One. 2011 Apr 04;6(4):e18299
pubmed: 21483697
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S193-9
pubmed: 24918595
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 4:S292-8
pubmed: 27404011
HIV AIDS (Auckl). 2017 Dec 18;10:1-8
pubmed: 29296100
Syst Rev. 2019 Jan 3;8(1):3
pubmed: 30606262
PLoS One. 2017 Apr 25;12(4):e0175928
pubmed: 28441458
PLoS One. 2016 Jul 21;11(7):e0158767
pubmed: 27441648
PLoS One. 2014 May 02;9(5):e96468
pubmed: 24788339
PLoS One. 2019 Mar 7;14(3):e0213571
pubmed: 30845185
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Health Educ Res. 2014 Feb;29(1):122-30
pubmed: 24293524
PLoS One. 2014 May 06;9(5):e83642
pubmed: 24801882
PLoS One. 2016 Jul 13;11(7):e0156909
pubmed: 27410966
Glob Public Health. 2019 Jan;14(1):91-111
pubmed: 29695201
Medicine (Baltimore). 2017 Jan;96(4):e5328
pubmed: 28121914
PLoS One. 2017 Oct 9;12(10):e0185929
pubmed: 29016651
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):291-299
pubmed: 29557854
J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):269-275
pubmed: 30531298
PLoS One. 2015 Mar 16;10(3):e0119484
pubmed: 25774677
PLoS One. 2016 Oct 26;11(10):e0160207
pubmed: 27783612
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S173-S182
pubmed: 29617775
PLoS One. 2014 May 06;9(5):e79524
pubmed: 24801073
J Acquir Immune Defic Syndr. 2016 Dec 15;73(5):564-571
pubmed: 27509246